URS
EPZM

Utah Retirement Systems’s Epizyme, Inc EPZM Stock Holding History

Utah Retirement Systems’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-43,202
Closed -$515K – 964
2020
Q3 		$515K Buy
+43,202
New +$579K 0.01% 814

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
KXA
KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Utah Retirement Systems's EPZM Position: Q4 2020 in Review

Utah Retirement Systems sold out of Epizyme, Inc (EPZM) in Q4 2020, closing a stake of 43,202 shares — an estimated $515K sold.

Utah Retirement Systems first reported a position in EPZM in Q3 2020 and held it in 1 quarter. The position peaked at $515K in Q3 2020. 137 funds tracked by Wall St. Rank hold EPZM as of Q4 2020.

  • Utah Retirement Systems reported no remaining Epizyme, Inc position as of Q4 2020 after selling out during the quarter.
  • Utah Retirement Systems sold 43,202 Epizyme, Inc shares in Q4 2020, an estimated $515K.
  • Utah Retirement Systems first reported a position in Epizyme, Inc in Q3 2020 and held it in 1 quarter.
  • Utah Retirement Systems's Epizyme, Inc position peaked at $515K in Q3 2020.
  • 137 funds tracked by Wall St. Rank held Epizyme, Inc as of Q4 2020.

Based on Utah Retirement Systems's 13F filing for Q4 2020, filed 16 Feb 2021.